Ingrid Petillon
About Ingrid Petillon
Ingrid Petillon is the Medical Oncology and Science Manager at Bristol-Myers Squibb in New York, with over 15 years of experience at the company and a Doctor of Pharmacy degree from Université Paris Descartes.
Title
Ingrid Petillon currently holds the position of Medical Oncology and Science Manager at Bristol-Myers Squibb, a leading global biopharmaceutical company based in New York, New York, United States.
Company
Ingrid Petillon has been with Bristol-Myers Squibb for over 15 years. The company is renowned for its focus on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Petillon’s role as a Medical Oncology and Science Manager places her at the forefront of scientific and medical advancements within the field of oncology.
Education and Expertise
Ingrid Petillon has an extensive educational background in pharmacy and medical sciences. She holds a Doctor of Pharmacy degree from Université Paris Descartes, where she studied from 1994 to 1999. She also completed a master's degree from 1999 to 2000. Her studies at these esteemed institutions have provided her with a solid foundation in both clinical and scientific aspects of pharmacy and oncology.
Background
Ingrid Petillon has a diverse background in pharmacy and medical oncology. She studied at Lycée International St Germain and later advanced her knowledge at Université Paris Descartes and through a master's program. Petillon has built a robust career spanning over 15 years at Bristol-Myers Squibb, where she has made significant contributions to the field of medical oncology.
International Experience
Ingrid Petillon possesses international experience, having studied and worked in both France and the United States. Her academic pursuits in France at Université Paris Descartes and professional tenure at Bristol-Myers Squibb in New York highlight her ability to operate effectively in diverse cultural and professional environments. This international exposure enhances her aptitude in addressing global healthcare challenges.